Skip to main content
SINPHAR logo

SINPHAR — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Open in API
Filings indexed 1,611 across all filing types
Latest filing 2019-11-08 Director's Dealing
Country TW Taiwan
Listing TW 1734

About SINPHAR

www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
108年10月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and senior management, showing their current holdings, pledged shares, and related party holdings. It is a disclosure of insider shareholdings and pledges rather than a financial report, earnings release, or management discussion. There is no indication of a meeting, voting results, or legal proceedings. The document is not a report publication announcement or certification but a direct disclosure of insider shareholdings. This fits the definition of Director's Dealing (DIRS), which covers reports of personal share transactions or holdings by company directors and executives. The document length is under 5,000 characters, but it contains substantive data on insider holdings, not just an announcement or link to a report. Therefore, the appropriate classification is DIRS with high confidence.
2019-11-08 Chinese
108年10月背書保證與資金貸與
Regulatory Filings Classification · 90% confidence The document contains financial data related to loan balances, endorsements, and guarantees for a company and its subsidiaries, presented in a tabular format. The data is for a specific month (October 2019) and is relatively short (615 characters). There is no indication that this is a full financial report like an Annual Report (10-K) or Interim Report (IR). It appears to be a regulatory disclosure of financial guarantees and endorsements, which is typical for a Regulatory Filing (RNS) category. The document does not announce a report publication nor is it a certification or a detailed financial report. Therefore, the best fit is Regulatory Filings (RNS).
2019-11-08 Chinese
108年10月營業收入
Interim / Quarterly Report Classification · 85% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 杏輝, with data for October 2019 (民國108年10月). It includes percentage changes compared to the previous year and explanatory notes about accounting standards and reporting practices. The document is short (772 characters) and contains financial data but is not a full financial report like an annual or interim report. It appears to be a periodic financial summary or revenue update rather than a comprehensive earnings release or detailed financial statement. Given the nature of the data (monthly revenue figures) and the absence of detailed financial statements or management discussion, the best fit is an Interim / Quarterly Report (IR), as it provides substantive financial data for a period shorter than a full fiscal year. Q3 2019
2019-11-08 Chinese
代重要子公司杏輝天力(杭州)藥業有限公司公告 董事會決議不分派股利
Notice of Dividend Amount Classification · 95% confidence The document is a short announcement from a company (杏輝) regarding a board resolution about dividend distribution, specifically stating that no dividend will be distributed for the 2018 fiscal year. It includes the board meeting date and dividend decision but does not contain financial statements or detailed financial data. The document length is only 494 characters, indicating it is a brief announcement rather than a full report. This fits the category of a Notice of Dividend Amount (DIV), which covers announcements about dividend decisions and payment details.
2019-10-31 Chinese
代重要子公司SUNETIC BIOTECH INC.公告 董事會決議不分派股利
Notice of Dividend Amount Classification · 95% confidence The document is a short announcement from a company (杏輝) regarding a board resolution not to distribute dividends for the 2018 fiscal year. It specifies the board meeting date and the dividend decision. The content is focused on dividend declaration details, not a full report or financial statements. The document length is only 500 characters, indicating it is a brief announcement rather than a detailed report. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2019-10-31 Chinese
108年09月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, supervisors, general managers, and their family members. It shows the number of shares held, changes in holdings, and other related data. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of it being a full financial report, earnings release, or management discussion. The document is not a brief announcement but a detailed disclosure of insider shareholdings. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades).
2019-10-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.